Viewing Study NCT01535157

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 6:51 PM
Ignite Modification Date: 2026-01-02 @ 4:59 PM
Study NCT ID: NCT01535157
Status: TERMINATED
Last Update Posted: 2020-08-27
First Post: 2012-02-03
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Fenretinide/LXS Oral Powder Plus Ketoconazole in Recurrent Ovarian Cancer
Sponsor: South Plains Oncology Consortium
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Ovarian Cancer View
None Cancer of Ovary View
None Cancer of the Ovary View
None Ovary Neoplasms View
None Primary Peritoneal Carcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Chemotherapy View